跳至主要内容
临床试验/CTRI/2023/08/056112
CTRI/2023/08/056112尚未招募3 期

EFFICACY OF DURVA TAILA UTTARBASTI IN THE MANAGEMENT OF STRICURE URETHRA AN OPEN LABELLED CLINICAL STUDY

DR IMRANNABI JABBARALI NADAF1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年8月15日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
WILL REDUCE THE SYMPTOMS OF URETHRAL STRICTURE EG DRIBBLING MICTURITION URINE STREAM WITHIN 7 DAYS WITH UTTARBASTI

研究概览

简要总结

AIM •To compareclinical efficacy of Durvatailauttarbastiin the management of urethral stricture.

OBJECTIVES•      To PrepareDurva Taila.

•      To study the effect of DurvaTailaUttarbastiin improving the subjective symptoms of urethral stricture.

•      Analysis of Durva Taila in wound healing by HPTLC method.

To attain the probable mode of action of effect of Durva Taila inUrethral stricture

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
25.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • Diagnosed cases of Stricture Urethra will be included Patients of either gender of age 25 TO 75years with history of stricture urethra of mild to moderate symptoms will be selected for the study.

排除标准

  • Age group below 25 years and above 75 years Patients of impacted calculus in the urethra and bladder Neck Benign Prostatic Hyperplasia Uncontrolled Diabetes Mellitus Nephritic Syndrome and Neoplasm of lower urinary tract Congenital and severely symptomatic Stricture Urethra HIV and HbsAg positive Carcinoma patients.

结局指标

主要结局

WILL REDUCE THE SYMPTOMS OF URETHRAL STRICTURE EG DRIBBLING MICTURITION URINE STREAM WITHIN 7 DAYS WITH UTTARBASTI

时间窗: 7 DAYS

次要结局

  • IMPROVE THE QUALITY OF LIFE AND REDUCE SYMPTOMS OF URETHRAL STRICTURE(7 DAYS)

研究者

发起方
DR IMRANNABI JABBARALI NADAF
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验